6 Analysts Assess Doximity: What You Need To Know
Portfolio Pulse from Benzinga Insights
Six analysts have recently updated their ratings on Doximity (NYSE:DOCS), showing a mix of indifference and slight bearishness, with four maintaining an indifferent stance and two somewhat bearish. The average 12-month price target for DOCS has been raised to $28.00, indicating a 12.0% increase from the previous target of $25.00. The company's financials reveal strong performance, with significant revenue growth, high net margin, and excellent ROE and ROA, suggesting a robust financial health and operational efficiency.
April 23, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Doximity's stock may see short-term positive movement due to the raised average price target and strong financial performance, despite mixed analyst ratings.
The increase in the average price target reflects a positive outlook from analysts, despite a mix of ratings. The company's strong financial performance, including high revenue growth, net margin, ROE, and ROA, further supports the potential for stock appreciation. The detailed financial metrics and analyst actions suggest investor confidence and market recognition, which could drive short-term positive momentum in DOCS's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100